References
- Burger JA. Nurture versus nature: the microenvironment in chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2011;2011:96–103.
- Cannons JL, Qi H, Lu KT, et al. Optimal germinal center responses require a multistage T cell: B cell adhesion process involving integrins, SLAM-associated protein, and CD84. Immunity. 2010;32:253–265.
- Qi H, Cannons JL, Klauschen F, et al. SAP-controlled T-B cell interactions underlie germinal centre formation. Nature. 2008;455:764–769.
- Wang N, Halibozek PJ, Yigit B, et al. Negative regulation of humoral immunity due to interplay between the SLAMF1, SLAMF5, and SLAMF6 Receptors. Front Immunol. 2015;6:158.
- Zhao F, Cannons JL, Dutta M, et al. Positive and negative signaling through SLAM receptors regulate synapse organization and thresholds of cytolysis. Immunity. 2012;36:1003–1016.
- De Salort J, Sintes J, Llinas L, et al. Expression of SLAM (CD150) cell-surface receptors on human B-cell subsets: from pro-B to plasma cells. Immunol Lett. 2011;134:129–136.
- Mikhalap SV, Shlapatska LM, Yurchenko OV, et al. The adaptor protein SH2D1A regulates signaling through CD150 (SLAM) in B cells. Blood. 2004;104:4063–4070.
- Yurchenko MY, Kovalevska LM, Shlapatska LM, et al. CD150 regulates JNK1/2 activation in normal and Hodgkin’s lymphoma B cells. Immunol Cell Biol. 2010;88:565–574.
- Punnonen J, Cocks BG, Carballido JM, et al. Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J Exp Med. 1997;185:993–1004.
- Nakajima H, Cella M, Langen H, et al. Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur J Immunol. 1999;29:1676–1683.
- de la Fuente MA, Tovar V, Villamor N, et al. Molecular characterization and expression of a novel human leukocyte cell-surface marker homologous to mouse Ly-9. Blood. 2001;97:3513–3520.
- Binsky-Ehrenreich I, Marom A, Sobotta MC, et al. CD84 is a survival receptor for CLL cells. Oncogene. 2014;33:1006–1016.
- Korver W, Singh S, Liu S, et al. The lymphoid cell surface receptor NTB-A: a novel monoclonal antibody target for leukaemia and lymphoma therapeutics. Br J Haematol. 2007;137:307–318.
- Yigit B, Halibozek PJ, Chen SS, et al. A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells. Oncotarget. 2016;7:26346–26360.
- Lee JK, Mathew SO, Vaidya SV, et al. CS1 (CRACC, CD319) induces proliferation and autocrine cytokine expression on human B lymphocytes. J Immunol. 2007;179:4672–4678.